Armata Pharmaceuticals, Inc.
ARMP · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $4 | $12 | $9 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $2 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $17 | $8 | $13 | $11 |
| Property Plant & Equip (Net) | $52 | $53 | $54 | $55 |
| Goodwill | $3 | $3 | $3 | $3 |
| Intangibles | $10 | $10 | $10 | $10 |
| Long-Term Investments | $0 | $0 | $5 | $5 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $6 | $1 | $1 |
| Total NC Assets | $73 | $73 | $74 | $75 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $90 | $81 | $87 | $86 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $136 | $117 | $107 | $43 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $2 | $2 | $4 |
| Total Curr. Liab. | $140 | $120 | $111 | $48 |
| LT Debt | $42 | $27 | $27 | $83 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $3 | $3 | $3 | $3 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $45 | $30 | $30 | $86 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $31 | $32 | $32 | $32 |
| Total Liabilities | $185 | $150 | $141 | $134 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$377 | -$351 | -$334 | -$328 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $281 | $281 | $280 | $279 |
| Total Equity | -$96 | -$70 | -$54 | -$48 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $90 | $81 | $87 | $86 |
| Net Debt | $163 | $140 | $123 | $117 |